Innospec Stock Net Income
| OCT Stock | EUR 72.50 1.00 1.36% |
As of the 15th of February 2026, Innospec retains the Market Risk Adjusted Performance of 0.3893, downside deviation of 1.44, and Risk Adjusted Performance of 0.102. Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Innospec, as well as the relationship between them. Please check out Innospec value at risk, expected short fall, and the relationship between the treynor ratio and downside variance to decide if Innospec is priced fairly, providing market reflects its last-minute price of 72.5 per share.
Innospec Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization 1.8 B | Enterprise Value Revenue 1.0772 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 32 M | 30.4 M | |
| Net Income Applicable To Common Shares | 152.9 M | 97.6 M | |
| Net Income | 32 M | 30.4 M |
Innospec | Net Income |
The Net Income trend for Innospec offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Innospec is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Innospec's Net Income Growth Pattern
Below is the plot of the Net Income of Innospec over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Innospec financial statement analysis. It represents the amount of money remaining after all of Innospec operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Innospec's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Innospec's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 35.6 M | 10 Years Trend |
|
Net Income |
| Timeline |
Innospec Net Income Regression Statistics
| Arithmetic Mean | 80,722,235 | |
| Geometric Mean | 72,408,356 | |
| Coefficient Of Variation | 42.54 | |
| Mean Deviation | 25,298,021 | |
| Median | 84,100,000 | |
| Standard Deviation | 34,335,865 | |
| Sample Variance | 1179T | |
| Range | 110.4M | |
| R-Value | (0.27) | |
| Mean Square Error | 1166.1T | |
| R-Squared | 0.07 | |
| Significance | 0.30 | |
| Slope | (1,833,618) | |
| Total Sum of Squares | 18863.2T |
Innospec Net Income History
Innospec 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Innospec's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Innospec.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Innospec on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Innospec or generate 0.0% return on investment in Innospec over 90 days. Innospec is related to or competes with Abbott Laboratories, DANAHER (DAPSG), Merck, Advanced Micro, Philip Morris, BANK OF CHINA, and TotalEnergies. Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals worldwide More
Innospec Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Innospec's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Innospec upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.44 | |||
| Information Ratio | 0.0747 | |||
| Maximum Drawdown | 6.3 | |||
| Value At Risk | (2.19) | |||
| Potential Upside | 3.01 |
Innospec Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innospec's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Innospec's standard deviation. In reality, there are many statistical measures that can use Innospec historical prices to predict the future Innospec's volatility.| Risk Adjusted Performance | 0.102 | |||
| Jensen Alpha | 0.1465 | |||
| Total Risk Alpha | 0.0606 | |||
| Sortino Ratio | 0.0793 | |||
| Treynor Ratio | 0.3793 |
Innospec February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.102 | |||
| Market Risk Adjusted Performance | 0.3893 | |||
| Mean Deviation | 1.16 | |||
| Semi Deviation | 0.9723 | |||
| Downside Deviation | 1.44 | |||
| Coefficient Of Variation | 829.52 | |||
| Standard Deviation | 1.53 | |||
| Variance | 2.33 | |||
| Information Ratio | 0.0747 | |||
| Jensen Alpha | 0.1465 | |||
| Total Risk Alpha | 0.0606 | |||
| Sortino Ratio | 0.0793 | |||
| Treynor Ratio | 0.3793 | |||
| Maximum Drawdown | 6.3 | |||
| Value At Risk | (2.19) | |||
| Potential Upside | 3.01 | |||
| Downside Variance | 2.07 | |||
| Semi Variance | 0.9453 | |||
| Expected Short fall | (1.84) | |||
| Skewness | 0.6564 | |||
| Kurtosis | 0.2539 |
Innospec Backtested Returns
Innospec appears to be very steady, given 3 months investment horizon. Innospec holds Efficiency (Sharpe) Ratio of 0.19, which attests that the entity had a 0.19 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Innospec, which you can use to evaluate the volatility of the firm. Please utilize Innospec's Downside Deviation of 1.44, risk adjusted performance of 0.102, and Market Risk Adjusted Performance of 0.3893 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Innospec holds a performance score of 15. The company retains a Market Volatility (i.e., Beta) of 0.46, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Innospec's returns are expected to increase less than the market. However, during the bear market, the loss of holding Innospec is expected to be smaller as well. Please check Innospec's value at risk, expected short fall, and the relationship between the treynor ratio and downside variance , to make a quick decision on whether Innospec's current trending patterns will revert.
Auto-correlation | 0.51 |
Modest predictability
Innospec has modest predictability. Overlapping area represents the amount of predictability between Innospec time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Innospec price movement. The serial correlation of 0.51 indicates that about 51.0% of current Innospec price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.51 | |
| Spearman Rank Test | 0.57 | |
| Residual Average | 0.0 | |
| Price Variance | 6.03 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Innospec Operating Income
Operating Income |
|
Based on the recorded statements, Innospec reported net income of 35.6 M. This is 395.82% lower than that of the Chemicals sector and 91.58% lower than that of the Materials industry. The net income for all Germany stocks is 93.77% higher than that of the company.
Innospec Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Innospec's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Innospec could also be used in its relative valuation, which is a method of valuing Innospec by comparing valuation metrics of similar companies.Innospec is currently under evaluation in net income category among its peers.
Innospec Fundamentals
| Return On Equity | -9.0E-4 | ||||
| Return On Asset | -7.0E-4 | ||||
| Profit Margin | (0.0007) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.63 B | ||||
| Shares Outstanding | 24.78 M | ||||
| Shares Owned By Insiders | 1.21 % | ||||
| Shares Owned By Institutions | 98.78 % | ||||
| Price To Earning | 20.78 X | ||||
| Price To Book | 1.64 X | ||||
| Price To Sales | 1.01 X | ||||
| Revenue | 1.85 B | ||||
| Gross Profit | 501.2 M | ||||
| EBITDA | 42.7 M | ||||
| Net Income | 35.6 M | ||||
| Cash And Equivalents | 123.5 M | ||||
| Cash Per Share | 5.05 X | ||||
| Total Debt | 518.6 M | ||||
| Debt To Equity | 29.10 % | ||||
| Current Ratio | 2.28 X | ||||
| Book Value Per Share | 44.11 X | ||||
| Cash Flow From Operations | 184.5 M | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 114.5 | ||||
| Number Of Employees | 2.45 K | ||||
| Beta | 0.88 | ||||
| Market Capitalization | 1.8 B | ||||
| Total Asset | 1.73 B | ||||
| Retained Earnings | 1.02 B | ||||
| Working Capital | 585.2 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.00 % | ||||
| Net Asset | 1.73 B | ||||
| Last Dividend Paid | 1.63 |
About Innospec Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Innospec's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innospec using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innospec based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Innospec Stock please use our How to Invest in Innospec guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.